Stephan A. Grupp, MD, PhD
Previous Record Next Record

Stephan A. Grupp, MD, PhD

Stephan A. Grupp, MD, PhD is the Director of Translational Research for the CCCR and his laboratory study the B cells that normally make immunoglobulins (anitbodies). When these cells do not mature properly, ALL is the result. Dr. Grupp's laboratory has identified a critical pathway, mTOR (molecular target of rapamycin), which is essential for normal B cell development; abnormalities in this pathway are fundamental to the development of ALL and many other types of cancer.